About
Kenneth Galbraith is a veteran biotechnology entrepreneur and investor with over 35 years of experience across life sciences, biotech, and healthcare sectors. He serves as Executive Partner and Board member of Syncona Investment Management Limited (SIML), the investment arm of FTSE-250 life sciences investor Syncona, having joined as Executive in Residence before being elevated in November 2024. He concurrently holds the role of Chair & CEO at Zymeworks Inc, a clinical-stage biopharmaceutical company, and previously co-founded Five Corners Capital and spent over a decade as General Partner at Ventures West Capital.
Areas of interest
longevitybiotechlife sciencesdeep scienceclinical-stage therapeuticsmedical devicespharmaceuticalhealthcareventure capital